ASH2L and neoplasm: Inhibiting additional members of the menin–MLL complex, MLL1 and Ash2L, similarly reduced tumor organoid growth and HIF target gene expression [303], suggesting the menin–MLL complex functions as a tumor promoter in endometrial cancer.